Every 10-Q that Envista Holdings Corporation (NVST) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow NVST and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full NVST filings page.
Envista Holdings reported stronger Q2 2026 results, with sales of $730.5 million, up 7.1% (core sales +5.0%), and net income of $53.7 million versus $26.4 million a year earlier. Gross margin improved to 55.7% and operating margin to 11.0%, supported by higher volume, pricing, and a $12.6 million U.S. tariff refund recorded in cost of sales.
For the first half of 2026, sales reached $1.44 billion and net income $92.4 million, more than double the prior year, while the effective tax rate declined to 27.0%. Both Specialty Products & Technologies and Equipment & Consumables increased sales and segment operating profit; segment operating profit for the half was $199.3 million.
Envista generated $115.9 million of operating cash flow in the first six months, funded the $54.7 million Versah acquisition, and returned cash via $103.0 million of share repurchases. Cash and cash equivalents were $1,125.6 million and total long‑term debt $1,436.3 million as of July 3, 2026, with compliance under its debt covenants.
Envista Holdings Corporation reported solid growth for the quarter ended April 3, 2026. Sales rose to $705.5 million, up from $616.9 million, with core sales increasing 9.5% on higher volume and pricing, especially in North America and Europe.
Net income more than doubled to $38.7 million from $18.0 million, and diluted EPS increased to $0.23 from $0.10. Gross margin improved to 55.3% as stronger volumes, pricing and favorable foreign exchange more than offset higher tariffs. Specialty Products & Technologies and Equipment & Consumables both expanded operating margins.
Envista closed the $54.7 million Versah acquisition to strengthen its implant portfolio and ended the quarter with $1,082.8 million in cash and cash equivalents and $1,439.1 million of long-term debt. After quarter-end, the board authorized a new $300 million stock repurchase program through December 31, 2029.
Envista Holdings (NVST) reported Q3 results with sales of $669.9 million, up from $601.0 million a year ago. Operating profit rose to $57.5 million from $20.9 million as gross profit improved to $370.2 million. Despite pre‑tax income of $49.9 million, the company recorded a net loss of $30.3 million due to income tax expense of $80.2 million, driven primarily by a change in indefinite reinvestment assertions related to a foreign subsidiary.
Specialty Products & Technologies delivered $431.5 million in revenue and Equipment & Consumables $238.4 million. For the nine months, sales were $1,968.9 million, with net income of $14.1 million versus a prior‑year loss that included significant impairments. Cash and equivalents were $1,133.9 million, supported by $167.7 million of operating cash flow. Long‑term debt was $1,445.4 million, reflecting revolver usage and term loans; the company repaid $116.3 million as its 2025 convertible notes matured. Shares outstanding were 164,426,233 as of October 24, 2025.